EquityFlow
›
Companies
› bit.bio
bit.bio
Biotech
· Cambridge, GB
Human cell coding company using OPTi-OX reprogramming technology.
Funding history
Date
Round
Amount
Nov 2021
Series B
Cambridge cell-coding biotech bit.bio raised a USD 103M Series B with Arch Ventures, Tencent and others.
$103M
Investors
Arch Ventures
Charles River Laboratories
Foresite Capital
Tencent
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →